Bone mesenchymal stem cells improve pregnancy outcome by inducing maternal tolerance to the allogeneic fetus in abortion-prone matings in mouse.

Placenta

Reproductive Medical Center, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China; Key Laboratory of Assisted Reproduction, Ministry of Education, Beijing, China; Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Beijing, China. Electronic address:

Published: November 2016

Introduction: The successful pregnancy depends on maternal immune tolerance against the fetus. It has been reported that MSCs (mesenchymal stem cells) could play a regulatory role on immune cells such as CD4T cells, macrophages and NK cells, but their effect on recurrent miscarriage is unknown.

Study Design: In a prospective study, the abortion-prone (CBA/J × DBA/2) H-2 × H-2 mice were utilized. Female CBA/J mice (8-10 weeks old) were injected with vehicle or MSCs via tail vein or uterine horns, and 14 days later, they were mated with DBA/2 males for the following experiments.

Results: Comparing with the control group, the embryo resorption rate in MSCs-horn injection group was dramatically decreased. MSCs were mainly located at the maternal-fetal interface, indicating that the reduction of resorption rate was due to MSCs' local effect. No matter which treatment was given, there was no significant difference in the levels of IL-4, IL-10, TNF-α and IFN-γ in CD4T cells and IL-10 and IL-12 in macrophages in spleens among each group. However, in contrast to other groups, the levels of IL-4 and IL-10 in CD4T cells localized at the maternal-fetal interface in MSCs-horn injection group were dramatically increased, and TNF-α and IFN-γ levels were notably decreased. While IL-10 expressed in macrophages was obviously higher than other groups and IL-12 in macrophages was significantly lower than other groups.

Conclusions: The findings indicate that MSCs injection through uterine horns could decrease embryo resorption rate.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.placenta.2016.08.089DOI Listing

Publication Analysis

Top Keywords

cd4t cells
12
resorption rate
12
mesenchymal stem
8
stem cells
8
uterine horns
8
embryo resorption
8
mscs-horn injection
8
injection group
8
group dramatically
8
maternal-fetal interface
8

Similar Publications

In Vitro Evaluation of Bunyavirus T Cell Immunity.

Methods Mol Biol

December 2024

Pediatric Infectious Disease and Center for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Characterization and quantitation of T cell responses following infection and/or vaccination can provide insight into mechanisms of host cell immunity that provide resolution of acute infection or protection from future infection or disease. While these types of studies are very advanced for viruses such as HIV, influenza, and SARS-CoV-2, they are less well developed for most of the Bunyaviruses. Cytotoxic CD8T cells are especially relevant in the context of viral infections since they recognize virus-infected cells via interaction of the T cell receptor with virally derived peptides presented in the context of MHCI.

View Article and Find Full Text PDF

Introduction: Cutaneous immune-mediated adverse drug reactions are more prevalent in people with human immunodeficiency virus (PWH). Severe cutaneous adverse drug reactions (SCAR) are a life-threatening subset of cutaneous adverse drug reactions (CADRs) and a significant public health issue in settings endemic for human immunodeficiency virus and tuberculosis. However, limited data are available on CADR requiring hospitalisation in African settings.

View Article and Find Full Text PDF
Article Synopsis
  • This study explores blood biomarkers that can predict responses to immune checkpoint inhibitors (ICIs) for patients with recurrent/metastatic head and neck squamous cell carcinoma, addressing challenges like tumor sample variability.
  • Researchers enrolled 100 patients and analyzed blood immune profiles, focusing on factors like tumor mutational burden (TMB) and PD-L1 scores, with a goal to find associations with treatment outcomes.
  • Key findings revealed that high levels of neutrophils and monocytes were linked to worse survival, while higher CD4T cells correlated with better outcomes, highlighting the potential of using blood tests for predicting ICI treatment responses.
View Article and Find Full Text PDF

High-dimensional profiling of immune responses to kidney transplant reveals heterogeneous T helper 1 and B cell effectors associated with rejection.

Am J Transplant

October 2024

Department of Surgery, Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA; Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Electronic address:

Article Synopsis
  • Rejection is a major cause of kidney transplant failure, and this study explores the immune cell types involved in different rejection types at a detailed level.
  • Researchers analyzed blood samples from 76 kidney transplant patients, using advanced techniques to identify specific CD4 T and B cell characteristics that differentiate stable transplants from those experiencing rejection.
  • Results revealed distinct immune cell profiles for T cell-mediated versus antibody-mediated rejection, enhancing our understanding of how rejection occurs and paving the way for targeted treatments.
View Article and Find Full Text PDF

Isotretinoin promotes elimination of translation-competent HIV latent reservoirs in CD4T cells.

PLoS Pathog

October 2024

Department of Microbiology, Immunology, and Tropical Medicine, George Washington University, Washington DC, United States of America.

Development of novel therapeutic strategies that reactivate latent HIV and sensitize reactivated cells to apoptosis is crucial towards elimination of the latent viral reservoir. Among the clinically relevant latency reversing agents (LRA) under investigation, the γc-cytokine IL-15 and the superagonist N-803 have been shown to reactivate latent HIV ex vivo and in vivo. However, their clinical benefit can be hindered by IL-15 promoting survival of infected cells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!